Desmoid Clinical Trial
Official title:
Cryotherapy in the Treatment of Desmoid Tumors
NCT number | NCT05091255 |
Other study ID # | CRYODESMO |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | May 20, 2021 |
Est. completion date | January 1, 2027 |
Desmoid tumor is a benign neoplasm with an unpredictable course and a high rate of local recurrence if treated surgically. Therefore, over time the surgical approach has become conservative, preferring simple observation or medical therapy in case of disease progression through the use of hormonal therapy and low-dose chemotherapy. Since this neoplasm remains benign, our study aims to avoid chemotherapy in patients usually young through the use of a minimally invasive treatment such as cryotherapy.
Status | Recruiting |
Enrollment | 94 |
Est. completion date | January 1, 2027 |
Est. primary completion date | January 1, 2027 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - histologic diagnosis of desmoid tumors - age > 18 years - abdominal and extra-abdominal desmoid tumors Exclusion Criteria: - contraindication to the procedure by the interventional radiologist in terms of tumor proximity to neurologic/vascular structures - retroperitoneal desmoid tumors - age < 18 years |
Country | Name | City | State |
---|---|---|---|
Italy | IRCCS Itituto Ortopedico Rizzoli | Bologna | BO |
Lead Sponsor | Collaborator |
---|---|
Istituto Ortopedico Rizzoli |
Italy,
Kujak JL, Liu PT, Johnson GB, Callstrom MR. Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors. Skeletal Radiol. 2010 Feb;39(2):175-82. doi: 10.1007/s00256-009-0801-z. Epub 2009 Sep 21. — View Citation
Redifer Tremblay K, Lea WB, Neilson JC, King DM, Tutton SM. Percutaneous cryoablation for the treatment of extra-abdominal desmoid tumors. J Surg Oncol. 2019 Sep;120(3):366-375. doi: 10.1002/jso.25597. Epub 2019 Jun 24. — View Citation
Schmitz JJ, Schmit GD, Atwell TD, Callstrom MR, Kurup AN, Weisbrod AJ, Morris JM. Percutaneous Cryoablation of Extraabdominal Desmoid Tumors: A 10-Year Experience. AJR Am J Roentgenol. 2016 Jul;207(1):190-5. doi: 10.2214/AJR.15.14391. Epub 2016 Apr 11. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | response to treatment | assessment of tumor response to treatment will be performed using the solid tumor response criteria | At baseline (time 0) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03966742 -
Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis
|
Phase 2 | |
Completed |
NCT03275818 -
Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma
|
Phase 2 | |
Active, not recruiting |
NCT04871282 -
A Study of AL102 in Patients With Progressing Desmoid Tumors
|
Phase 2/Phase 3 | |
Recruiting |
NCT05284305 -
Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History.
|
||
Active, not recruiting |
NCT01273168 -
Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
|
Phase 1 | |
Recruiting |
NCT06268457 -
Arterial Chemoembolization for the Treatment of Desmoid Fibromatosis
|
||
Recruiting |
NCT06224283 -
Radiomics Compared With Conventional Response Criteria for Predicting Progression of Desmoid Tumor After Cryoablation
|
||
Withdrawn |
NCT02557854 -
HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors
|
Phase 1 | |
Recruiting |
NCT05490667 -
Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor
|
N/A | |
Not yet recruiting |
NCT06355921 -
A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patients With Desmoid Tumors
|
N/A |